Stock Events

Stock Events

Kura Oncology 

$13.25
57
+$0.10+0.76% 20:00 Today
-$0.05-0.41%20:55After hours

Statistics

Day High
13.27
Day Low
12.89
52W High
13.9
52W Low
7.36
Volume
1,312,708
Avg. Volume
1,817,449
Mkt Cap
1.18B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.88
-0.66
-0.44
-0.22
Expected EPS
-0.815382
Actual EPS
N/A

Financials

-412.95%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
67.48MRevenue
-278.67MNet Income

Analyst Ratings

25.00Average Price Target
The highest estimate is 38.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KURA. It's not an investment recommendation.
Microsoft
13
MSFT
NVIDIA
13
NVDA
Amazon
11
AMZN
Meta Platforms
11
META

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences has a strong portfolio in oncology and hematology, making it a direct competitor in cancer treatment.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation specializes in oncology products, competing in similar markets as Kura Oncology.
Merck
MRK
Mkt Cap366B
Merck & Co. has a broad oncology portfolio, including therapies that could compete with Kura Oncology's treatments.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb offers a wide range of cancer treatments, posing competition to Kura Oncology's product pipeline.
Novartis
NVS
Mkt Cap292.35B
Novartis AG has extensive research and development in oncology, competing with Kura Oncology in developing cancer therapies.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics, including oncology, which puts it in competition with Kura Oncology.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a significant presence in oncology, making it a competitor in the cancer treatment market.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its pharmaceuticals division, competes in the oncology space, offering treatments that could rival Kura Oncology's.

About

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Show more...
CEO
Troy Wilson
Employees
260
Country
United States
ISIN
US50127T1097
WKN
000A143UH

Listings

STU
DE
KUR.STU
XNAS
US
KURA
BOATS
BOATS
KURA.BOATS
F
DE
KUR.F

0 Comments

Share your thoughts

FAQ

What is Kura Oncology stock price today?▼
The current price of KURA is $13.25 USD — it has increased by +0.76% in the past 24 hours. Watch Kura Oncology stock price performance more closely on the chart.
What is Kura Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kura Oncology stocks are traded under the ticker KURA.
Is Kura Oncology stock price growing?▼
KURA stock has risen by +4.66% compared to the previous week, the month change is a +39.92% rise, over the last year Kura Oncology has showed a +62.98% increase.
What is Kura Oncology market cap?▼
Today Kura Oncology has the market capitalization of 1.18B
When is the next Kura Oncology earnings date?▼
Kura Oncology is going to release the next earnings report on October 29, 2026.
What were Kura Oncology earnings last quarter?▼
KURA earnings for the last quarter are -0.77 USD per share, whereas the estimation was -0.88 USD resulting in a +12.23% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kura Oncology revenue for the last year?▼
Kura Oncology revenue for the last year amounts to 67.48M USD.
What is Kura Oncology net income for the last year?▼
KURA net income for the last year is -278.67M USD.
How many employees does Kura Oncology have?▼
As of September 04, 2026, the company has 260 employees.
In which sector is Kura Oncology located?▼
Kura Oncology operates in the Health & Wellness sector.
When did Kura Oncology complete a stock split?▼
Kura Oncology has not had any recent stock splits.
Where is Kura Oncology headquartered?▼
Kura Oncology is headquartered in SAN DIEGO, United States.